Seletracetam: Clinical Trials

3 withdrawn, 2 completed. 3 Phase 2, 3 Phase 3.

By phase and status

Phase	Trials	Status
Phase 2	3	Completed 2, Withdrawn 1
Phase 3	3	Withdrawn 3

Follow Seletracetam: new trials by email Literature Review of Seletracetam trials Research Report on Seletracetam

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy Seletracetam (ucb 44212) - Epilepsy	Phase 3	Withdrawn	UCB Pharma		2008-05-01	2012-05-28
A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures Seletracetam - Epilepsies, Partial	Phase 2 / Phase 3	Withdrawn	UCB Pharma		2008-05-01	2012-05-28
Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy. Seletracetam (ucb 44212) - Epilepsy	Phase 3	Withdrawn	UCB Pharma		2006-02-01	2012-03-20
Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam Seletracetam (UCB44212) - Epilepsy, Partial	Phase 2	Completed	UCB Pharma SA	59	2005-08-31	2023-09-07
Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures Seletracetam (ucb 44212) - Epilepsy, Partial	Phase 2	Completed	UCB S.A. - Pharma Sector	31	2005-05-19	2024-03-29

Conditions studied

Epilepsy (5)  ·  Epilepsies, Partial (3)

Sponsors

UCB Pharma (3)  ·  UCB Pharma SA (1)  ·  UCB S.A. - Pharma Sector (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Barbara Bennett, PhD (3)